Arijit Bhowmick

Director, Oligonucleotide Therapeutics


New York/Kolkata


PhD in structural immunology from National Institute of Immunology, New Delhi, India. Postdoctoral research in chemically modified RNA therapeutics at Albert Einstein College of Medicine, NY.

Previous Experience:

Prior to Insitro I worked at Regeneron Pharmaceuticals where I built and led Regeneron’s Nucleic Acid Therapeutics group under Regenron Genetics Medicine (RGM)

Responsibilities at insitro:

Leading oligonucleotide drug discovery and development across targets and therapeutic areas.